... were normal. Conclusions: Thyroid hormone replacement therapy should be considered based on biological data in patients with hyperthyrotropinemia who have a homozygous R450H mutation of the TSHR gene even if they do not exhibit obvious hypothyroidism in infancy. 17 09 2007 26 06 2008 6 6...

...Rena Vassilopoulou-Sellin; Mary Jean Klein; Bartlett D. Moore; Hubert L. Reid; Joann Ater; Hallie A. Zietz We evaluated the growth response of 20 childhood cancer survivors who received growth hormone (GH) replacement therapy (0.3 mg/kg/week) for at least 12 months. In all subjects, GH deficiency...

...Gudmundur Johannsson; Helena Filipsson; Ragnhildur Bergthorsdottir; Hans Lennernäs; Stanko Skrtic Background: Glucocorticoid (GC) deficiency is a consequence of various disorders that are by themselves rare. Because of this low prevalence, the low cost of GC replacement therapy and the belief...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2001 Hypothyroidism Replacement therapy Thyrotropin Thyroxine Triiodothyronine Euthyroidism Thyroid...

... to their target height. The full catch-up growth to the target height demonstrated in these patients suggests that replacement therapy should be started early and continued until adulthood. Height at onset of puberty is an important variable which might significantly influence the adult height. The significant...